Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: recent developments and future perspectives

Chronic inflammatory diseases of the lung are some of the leading causes of mortality and significant morbidity worldwide. Despite the tremendous burden these conditions put on global healthcare, treatment options for most of these diseases remain scarce. Inhaled corticosteroids and beta-adrenergic...

Descripción completa

Detalles Bibliográficos
Autores principales: Plichta, Jacek, Kuna, Piotr, Panek, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272527/
https://www.ncbi.nlm.nih.gov/pubmed/37334374
http://dx.doi.org/10.3389/fimmu.2023.1207641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272527/
https://www.ncbi.nlm.nih.gov/pubmed/37334374
http://dx.doi.org/10.3389/fimmu.2023.1207641

Ejemplares similares